Jia Jenny Liu: Implementing Tumor-Agnostic Therapies in Oncology
Jia Jenny Liu/LinkedIn

Jia Jenny Liu: Implementing Tumor-Agnostic Therapies in Oncology

Jia Jenny Liu, Translational Lead of Early Phase Drug Development at The Kinghorn Cancer Centre, shared a post by ESMO on X:

“Tumour-agnostic therapies are accelerating, but implementation is lagging behind science.

Looking forward to discussing where the real gaps are at this upcoming ESMO Therapeutic Landscapes webinar.”

Quoting ESMO‘s post on X:

“Discover how tumour‑agnostic therapies are changing oncology with the upcoming Therapeutic Landscapes Webinar.

Register now with your ESMO account.”

Jia (Jenny) Liu

Other articles featuring Jia Jenny Liu on OncoDaily.